Skip to main content
Top
Published in: Current Infectious Disease Reports 1/2013

01-02-2013 | Intra-abdominal Infections, Hepatitis, and Gastroenteritis (DA Bobak, Section Editor)

The Role of the Manipulation of the Gut Microbiota in Obesity

Authors: Matthieu Million, Didier Raoult

Published in: Current Infectious Disease Reports | Issue 1/2013

Login to get access

Abstract

The manipulation of the gut microbiota by diet, antibiotics, or probiotics could promote, prevent, or reverse the development of specific diseases, including obesity. A link has been proposed between obesity and the growth promoters (probiotics and antibiotics) that have been used in animals for more than 40 years to induce weight gain. Several species of the Lactobacillus genus that are frequently used as probiotics for human consumption merit particular attention because they are increased in the gut microbiota under high-fat diets, are more abundant in obese humans, and are selected by growth-promoter antibiotics; moreover, the administration of these bacteria in experimental models is linked to the development of obesity. However, other species or strains of the same genus are associated with an antiobesity effect. Newborns and infants are a particularly susceptible population in which the administration of antibiotics or probiotics could be related to the development of obesity in adulthood.
Literature
1.
2.
go back to reference Raoult D. The globalization of intestinal microbiota. Eur J Clin Microbiol Infect Dis. 2010;29:1049–50.PubMedCrossRef Raoult D. The globalization of intestinal microbiota. Eur J Clin Microbiol Infect Dis. 2010;29:1049–50.PubMedCrossRef
3.
go back to reference Pérez Guerra N, Pastrana Castro L. Probiotics: production, evaluation and uses in animal feed. Biotechnol Appl Biochem, Kerala, India.2009.ISBN: 978-81-308-0323-4. Pérez Guerra N, Pastrana Castro L. Probiotics: production, evaluation and uses in animal feed. Biotechnol Appl Biochem, Kerala, India.2009.ISBN: 978-81-308-0323-4.
4.
go back to reference Tannock GW. Probiotics a critical review. Wymondham: Horizon Scientific Press; 1999. ISBN 1-898486-15-8. Tannock GW. Probiotics a critical review. Wymondham: Horizon Scientific Press; 1999. ISBN 1-898486-15-8.
6.
go back to reference Merhej V, Armougom F, Robert C, Raoult D. Genome sequence of Lactobacillus ingluviei, bacterium associated with weight gain in animals. J Bacteriol. 2012;194:5697. Merhej V, Armougom F, Robert C, Raoult D. Genome sequence of Lactobacillus ingluviei, bacterium associated with weight gain in animals. J Bacteriol. 2012;194:5697.
7.
go back to reference Khan M, Raoult D, Richet H, et al. Growth-promoting effects of single-dose intragastrically administered probiotics in chickens. Br Poult Sci. 2007;48:732–5.PubMedCrossRef Khan M, Raoult D, Richet H, et al. Growth-promoting effects of single-dose intragastrically administered probiotics in chickens. Br Poult Sci. 2007;48:732–5.PubMedCrossRef
8.
go back to reference Angelakis E, Raoult D. The increase of Lactobacillus species in the gut flora of newborn broiler chicks and ducks is associated with weight gain. PLoS One. 2010;5:e10463.PubMedCrossRef Angelakis E, Raoult D. The increase of Lactobacillus species in the gut flora of newborn broiler chicks and ducks is associated with weight gain. PLoS One. 2010;5:e10463.PubMedCrossRef
9.
go back to reference Angelakis E, Bastelica D. Ben Amara A et al. An evaluation of the effects of Lactobacillus ingluviei on body weight, the intestinal microbiome and metabolism in mice. Microb Pathog. 2012;52:61–8.PubMedCrossRef Angelakis E, Bastelica D. Ben Amara A et al. An evaluation of the effects of Lactobacillus ingluviei on body weight, the intestinal microbiome and metabolism in mice. Microb Pathog. 2012;52:61–8.PubMedCrossRef
10.
11.
go back to reference Intestinal Networks in Health and Disease. Nature. 2012;474:297–336. Intestinal Networks in Health and Disease. Nature. 2012;474:297–336.
12.
go back to reference •• Angelakis E, Armougom F, Million M, Raoult D. The relationship between gut microbiota and weight gain in humans. Future Microbiol. 2012;7:91–109. A review linking gut microbiota and obesity with a meta-analysis reporting a consistent statistical anti-obesity effect of bifidobacteria.PubMedCrossRef •• Angelakis E, Armougom F, Million M, Raoult D. The relationship between gut microbiota and weight gain in humans. Future Microbiol. 2012;7:91–109. A review linking gut microbiota and obesity with a meta-analysis reporting a consistent statistical anti-obesity effect of bifidobacteria.PubMedCrossRef
13.
go back to reference Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature. 2006;444:1022–3.PubMedCrossRef Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature. 2006;444:1022–3.PubMedCrossRef
14.
go back to reference Turnbaugh PJ, Ley RE, Mahowald MA, et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444:1027–31.PubMedCrossRef Turnbaugh PJ, Ley RE, Mahowald MA, et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444:1027–31.PubMedCrossRef
15.
go back to reference Armougom F, Henry M, Vialettes B, et al. Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and Methanogens in anorexic patients. PLoS One. 2009;4:e7125.PubMedCrossRef Armougom F, Henry M, Vialettes B, et al. Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and Methanogens in anorexic patients. PLoS One. 2009;4:e7125.PubMedCrossRef
16.
go back to reference • Stsepetova J, Sepp E, Kolk H, et al. Diversity and metabolic impact of intestinal Lactobacillus species in healthy adults and the elderly. Br J Nutr. 2011;105:1235–44. Another team reporting a link between gut microbiota Lactobacillus and human weight.PubMedCrossRef • Stsepetova J, Sepp E, Kolk H, et al. Diversity and metabolic impact of intestinal Lactobacillus species in healthy adults and the elderly. Br J Nutr. 2011;105:1235–44. Another team reporting a link between gut microbiota Lactobacillus and human weight.PubMedCrossRef
17.
go back to reference Koren O, Goodrich JK, Cullender TC, et al. Host Remodeling of the Gut Microbiome and Metabolic Changes during Pregnancy. Cell. 2012;150:470–80.PubMedCrossRef Koren O, Goodrich JK, Cullender TC, et al. Host Remodeling of the Gut Microbiome and Metabolic Changes during Pregnancy. Cell. 2012;150:470–80.PubMedCrossRef
18.
go back to reference Santacruz A, Collado MC, Garcia-Valdes L, et al. Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women. Br J Nutr. 2010;104:83–92.PubMedCrossRef Santacruz A, Collado MC, Garcia-Valdes L, et al. Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women. Br J Nutr. 2010;104:83–92.PubMedCrossRef
19.
go back to reference Arumugam M, Raes J, Pelletier E, et al. Enterotypes of the human gut microbiome. Nature. 2011;473:174–80.PubMedCrossRef Arumugam M, Raes J, Pelletier E, et al. Enterotypes of the human gut microbiome. Nature. 2011;473:174–80.PubMedCrossRef
20.
go back to reference Zupancic ML, Cantarel BL, Liu Z, et al. Analysis of the gut microbiota in the old order amish and its relation to the metabolic syndrome. PLoS One. 2012;7:e43052.PubMedCrossRef Zupancic ML, Cantarel BL, Liu Z, et al. Analysis of the gut microbiota in the old order amish and its relation to the metabolic syndrome. PLoS One. 2012;7:e43052.PubMedCrossRef
21.
go back to reference Ravussin Y, Koren O, Spor A, et al. Responses of gut microbiota to diet composition and weight loss in lean and obese mice. Obesity (Silver Spring). 2012;20:738–47.CrossRef Ravussin Y, Koren O, Spor A, et al. Responses of gut microbiota to diet composition and weight loss in lean and obese mice. Obesity (Silver Spring). 2012;20:738–47.CrossRef
22.
go back to reference • Murphy EF, Cotter PD, Hogan A, et al. Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity. Gut. 2012 Aug 9. epub ahead of print. High-fat diet induces a significant increase in Firmicutes and particularly Lactobacillus in mice. • Murphy EF, Cotter PD, Hogan A, et al. Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity. Gut. 2012 Aug 9. epub ahead of print. High-fat diet induces a significant increase in Firmicutes and particularly Lactobacillus in mice.
23.
go back to reference Lam YY, Ha CW, Campbell CR, et al. Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice. PLoS One. 2012;7:e34233.PubMedCrossRef Lam YY, Ha CW, Campbell CR, et al. Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice. PLoS One. 2012;7:e34233.PubMedCrossRef
24.
go back to reference Cani PD, Bibiloni R, Knauf C, et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes. 2008;57:1470–81.PubMedCrossRef Cani PD, Bibiloni R, Knauf C, et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes. 2008;57:1470–81.PubMedCrossRef
25.
go back to reference Million M, Maraninchi M, Henry M, et al. Obesity-associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii. Int J Obes (Lond). 2012;36:817–25.CrossRef Million M, Maraninchi M, Henry M, et al. Obesity-associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii. Int J Obes (Lond). 2012;36:817–25.CrossRef
26.
go back to reference Million M, Angelakis E, Paul M, et al. Comparative meta-analysis of the effect of Lactobacillus species on weight gain in humans and animals. Microb Pathog. 2012;53:100–8.PubMedCrossRef Million M, Angelakis E, Paul M, et al. Comparative meta-analysis of the effect of Lactobacillus species on weight gain in humans and animals. Microb Pathog. 2012;53:100–8.PubMedCrossRef
27.
go back to reference Zhang C, Zhang M, Pang X, et al. Structural resilience of the gut microbiota in adult mice under high-fat dietary perturbations. ISME J. 2012 Apr 12. Epub ahead of print. Zhang C, Zhang M, Pang X, et al. Structural resilience of the gut microbiota in adult mice under high-fat dietary perturbations. ISME J. 2012 Apr 12. Epub ahead of print.
28.
29.
go back to reference Turnbaugh PJ, Backhed F, Fulton L, et al. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe. 2008;3:213–23.PubMedCrossRef Turnbaugh PJ, Backhed F, Fulton L, et al. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe. 2008;3:213–23.PubMedCrossRef
30.
go back to reference •• Vijay-Kumar M, Aitken JD, Carvalho FA, et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science. 2010;328:228–31. This study confirmed that gut transplantation led to transmission of obese traits (adiposity) suggesting that modification of the intestinal flora is a contributing factor in the development of obesity.PubMedCrossRef •• Vijay-Kumar M, Aitken JD, Carvalho FA, et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science. 2010;328:228–31. This study confirmed that gut transplantation led to transmission of obese traits (adiposity) suggesting that modification of the intestinal flora is a contributing factor in the development of obesity.PubMedCrossRef
31.
go back to reference Blaser MJ, Falkow S. What are the consequences of the disappearing human microbiota? Nat Rev Microbiol. 2009;7:887–94.PubMedCrossRef Blaser MJ, Falkow S. What are the consequences of the disappearing human microbiota? Nat Rev Microbiol. 2009;7:887–94.PubMedCrossRef
32.
go back to reference Dubray C, Ibrahim SA, Abdelmutalib M, et al. Treatment of severe malnutrition with 2-day intramuscular ceftriaxone vs 5-day amoxicillin. Ann Trop Paediatr. 2008;28:13–22.PubMedCrossRef Dubray C, Ibrahim SA, Abdelmutalib M, et al. Treatment of severe malnutrition with 2-day intramuscular ceftriaxone vs 5-day amoxicillin. Ann Trop Paediatr. 2008;28:13–22.PubMedCrossRef
33.
go back to reference Robinson P. Controlled trial of aureomycin in premature twins and triplets. Lancet. 1952;259:52.CrossRef Robinson P. Controlled trial of aureomycin in premature twins and triplets. Lancet. 1952;259:52.CrossRef
34.
go back to reference Haight TH, Pierce WE. Effect of prolonged antibiotic administration of the weight of healthy young males. J Nutr. 1955;56:151–61.PubMed Haight TH, Pierce WE. Effect of prolonged antibiotic administration of the weight of healthy young males. J Nutr. 1955;56:151–61.PubMed
35.
go back to reference Patterson PR. Minocycline in the antibiotic regimen of cystic fibrosis patients: weight gain and clinical improvement. Clin Pediatr [Phila]. 1977;16:60–3.CrossRef Patterson PR. Minocycline in the antibiotic regimen of cystic fibrosis patients: weight gain and clinical improvement. Clin Pediatr [Phila]. 1977;16:60–3.CrossRef
36.
go back to reference Pirzada OM, McGaw J, Taylor CJ, Everard ML. Improved lung function and body mass index associated with long-term use of Macrolide antibiotics. J Cyst Fibros. 2003;2:69–71.PubMedCrossRef Pirzada OM, McGaw J, Taylor CJ, Everard ML. Improved lung function and body mass index associated with long-term use of Macrolide antibiotics. J Cyst Fibros. 2003;2:69–71.PubMedCrossRef
37.
go back to reference Southern KW, Barker PM, Solis-Moya A, Patel L. Macrolide antibiotics for cystic fibrosis. Cochrane Database Syst Rev. 2011;12:CD002203.PubMed Southern KW, Barker PM, Solis-Moya A, Patel L. Macrolide antibiotics for cystic fibrosis. Cochrane Database Syst Rev. 2011;12:CD002203.PubMed
38.
go back to reference Saiman L, Mayer-Hamblett N, Anstead M, et al. Open-label, follow-on study of azithromycin in pediatric patients with CF uninfected with Pseudomonas aeruginosa. Pediatr Pulmonol. 2012;47:641–8.PubMedCrossRef Saiman L, Mayer-Hamblett N, Anstead M, et al. Open-label, follow-on study of azithromycin in pediatric patients with CF uninfected with Pseudomonas aeruginosa. Pediatr Pulmonol. 2012;47:641–8.PubMedCrossRef
39.
go back to reference Mansi Y, Abdelaziz N, Ezzeldin Z, Ibrahim R. Randomized controlled trial of a high dose of oral erythromycin for the treatment of feeding intolerance in preterm infants. Neonatology. 2011;100:290–4.PubMedCrossRef Mansi Y, Abdelaziz N, Ezzeldin Z, Ibrahim R. Randomized controlled trial of a high dose of oral erythromycin for the treatment of feeding intolerance in preterm infants. Neonatology. 2011;100:290–4.PubMedCrossRef
40.
go back to reference Garly ML, Bale C, Martins CL, et al. Prophylactic antibiotics to prevent pneumonia and other complications after measles: community based randomised double blind placebo controlled trial in Guinea-Bissau. BMJ. 2006;333:1245.PubMedCrossRef Garly ML, Bale C, Martins CL, et al. Prophylactic antibiotics to prevent pneumonia and other complications after measles: community based randomised double blind placebo controlled trial in Guinea-Bissau. BMJ. 2006;333:1245.PubMedCrossRef
41.
go back to reference Lane JA, Murray LJ, Harvey IM, et al. Randomised clinical trial: Helicobacter pylori eradication is associated with a significantly increased body mass index in a placebo-controlled study. Aliment Pharmacol Ther. 2011;33:922–9.PubMedCrossRef Lane JA, Murray LJ, Harvey IM, et al. Randomised clinical trial: Helicobacter pylori eradication is associated with a significantly increased body mass index in a placebo-controlled study. Aliment Pharmacol Ther. 2011;33:922–9.PubMedCrossRef
42.
go back to reference Cho I, Yamanishi S, Cox L, et al. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature. 2012;488:621–6.PubMedCrossRef Cho I, Yamanishi S, Cox L, et al. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature. 2012;488:621–6.PubMedCrossRef
43.
go back to reference •• Trasande L, Blustein J, Liu M, et al. Infant antibiotic exposures and early-life body mass. Int J Obes [Lond]. 2012 Aug 21. Epub ahead of print. A study that confirm the hypothesized link between antibiotic in early infancy and overweight in childhood. •• Trasande L, Blustein J, Liu M, et al. Infant antibiotic exposures and early-life body mass. Int J Obes [Lond]. 2012 Aug 21. Epub ahead of print. A study that confirm the hypothesized link between antibiotic in early infancy and overweight in childhood.
44.
go back to reference Thuny F, Richet H, Casalta JP, et al. Vancomycin treatment of infective endocarditis is linked with recently acquired obesity. PLoS One. 2010;5:e9074.PubMedCrossRef Thuny F, Richet H, Casalta JP, et al. Vancomycin treatment of infective endocarditis is linked with recently acquired obesity. PLoS One. 2010;5:e9074.PubMedCrossRef
45.
go back to reference Dethlefsen L, Huse S, Sogin ML, Relman DA. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol. 2008;6:e280.PubMedCrossRef Dethlefsen L, Huse S, Sogin ML, Relman DA. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol. 2008;6:e280.PubMedCrossRef
46.
go back to reference Dunham H, Casas I, Edens F, et al. Avian growth depression in chickens induced by environmental, microbiological, or nutritional stress is moderated by probiotic administrations of Lactobacillus reuteri. Biosci Microflora. 1998;17:133–9. Dunham H, Casas I, Edens F, et al. Avian growth depression in chickens induced by environmental, microbiological, or nutritional stress is moderated by probiotic administrations of Lactobacillus reuteri. Biosci Microflora. 1998;17:133–9.
47.
go back to reference Nahashon SN, Nakaue HS, Snyder SP, Mirosh LW. Performance of single comb White Leghorn layers fed corn-soybean meal and barley-corn-soybean meal diets supplemented with a direct-fed microbial. Poult Sci. 1994;73:1712–23.PubMedCrossRef Nahashon SN, Nakaue HS, Snyder SP, Mirosh LW. Performance of single comb White Leghorn layers fed corn-soybean meal and barley-corn-soybean meal diets supplemented with a direct-fed microbial. Poult Sci. 1994;73:1712–23.PubMedCrossRef
48.
go back to reference Robinson EL, Thompson WL. Effect on weight gain of the addition of Lactobacillus acidophilus to the formula of newborn infants. J Pediatr. 1952;41:395–8.PubMedCrossRef Robinson EL, Thompson WL. Effect on weight gain of the addition of Lactobacillus acidophilus to the formula of newborn infants. J Pediatr. 1952;41:395–8.PubMedCrossRef
49.
go back to reference •• Kadooka Y, Sato M, Imaizumi K, et al. Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. Eur J Clin Nutr. 2010;64:636–43. The first randomized control trial linking Lactobacillus administration and a significant anti-obesity effect in humans.PubMedCrossRef •• Kadooka Y, Sato M, Imaizumi K, et al. Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. Eur J Clin Nutr. 2010;64:636–43. The first randomized control trial linking Lactobacillus administration and a significant anti-obesity effect in humans.PubMedCrossRef
50.
go back to reference Lee K, Paek K, Lee HY, et al. Antiobesity effect of trans-10, cis-12-conjugated linoleic acid-producing Lactobacillus plantarum PL62 on diet-induced obese mice. J Appl Microbiol. 2007;103:1140–6.PubMedCrossRef Lee K, Paek K, Lee HY, et al. Antiobesity effect of trans-10, cis-12-conjugated linoleic acid-producing Lactobacillus plantarum PL62 on diet-induced obese mice. J Appl Microbiol. 2007;103:1140–6.PubMedCrossRef
51.
go back to reference • Abrahamsson TR, Sinkiewicz G, Jakobsson T, et al. Probiotic lactobacilli in breast milk and infant stool in relation to oral intake during the first year of life. J Pediatr Gastroenterol Nutr. 2009;49:349–54. Study establishing that probiotic administration during infancy lead to protracted alteration of the gut microbiota in humans.PubMedCrossRef • Abrahamsson TR, Sinkiewicz G, Jakobsson T, et al. Probiotic lactobacilli in breast milk and infant stool in relation to oral intake during the first year of life. J Pediatr Gastroenterol Nutr. 2009;49:349–54. Study establishing that probiotic administration during infancy lead to protracted alteration of the gut microbiota in humans.PubMedCrossRef
52.
go back to reference Nagpal R, Kumar A, Kumar M, et al. Probiotics, their health benefits and applications for developing healthier foods: a review. FEMS Microbiol Lett. 2012 May 9. Epub ahead of print. Nagpal R, Kumar A, Kumar M, et al. Probiotics, their health benefits and applications for developing healthier foods: a review. FEMS Microbiol Lett. 2012 May 9. Epub ahead of print.
53.
go back to reference Robinson CJ, Young VB. Antibiotic administration alters the community structure of the gastrointestinal micobiota. Gut Microbes. 2010;1:279–84.PubMedCrossRef Robinson CJ, Young VB. Antibiotic administration alters the community structure of the gastrointestinal micobiota. Gut Microbes. 2010;1:279–84.PubMedCrossRef
54.
go back to reference Patrone V, Ferrari S, Lizier M, et al. Short-term modifications in the distal gut microbiota of weaning mice induced by a high-fat diet. Microbiology. 2012;158:983–92.PubMedCrossRef Patrone V, Ferrari S, Lizier M, et al. Short-term modifications in the distal gut microbiota of weaning mice induced by a high-fat diet. Microbiology. 2012;158:983–92.PubMedCrossRef
55.
go back to reference Klare I, Konstabel C, Werner G, et al. Antimicrobial susceptibilities of Lactobacillus, Pediococcus and Lactococcus human isolates and cultures intended for probiotic or nutritional use. J Antimicrob Chemother. 2007;59:900–12.PubMedCrossRef Klare I, Konstabel C, Werner G, et al. Antimicrobial susceptibilities of Lactobacillus, Pediococcus and Lactococcus human isolates and cultures intended for probiotic or nutritional use. J Antimicrob Chemother. 2007;59:900–12.PubMedCrossRef
Metadata
Title
The Role of the Manipulation of the Gut Microbiota in Obesity
Authors
Matthieu Million
Didier Raoult
Publication date
01-02-2013
Publisher
Current Science Inc.
Published in
Current Infectious Disease Reports / Issue 1/2013
Print ISSN: 1523-3847
Electronic ISSN: 1534-3146
DOI
https://doi.org/10.1007/s11908-012-0301-5

Other articles of this Issue 1/2013

Current Infectious Disease Reports 1/2013 Go to the issue

HIV/AIDS (R MacArthur, Section Editor)

HCV Enters the Twenty-First Century

Intra-abdominal Infections, Hepatitis, and Gastroenteritis (D Bobak, Section Editor)

The Role of Antibiotic Therapy in the Management of Acute Appendicitis

HIV/AIDS (R MacArthur, Section Editor)

The Hispanic HIV Epidemic

HIV/AIDS (R MacArthur, Section Editor)

The Twin Epidemics of Tuberculosis and HIV

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.